Scinai Immunotherapeutics
$0.58
0
-$0.03-4.18% Tuesday 03:29
Statistics
Day High
0.58
Day Low
0.44
52W High
-
52W Low
-
Volume
3,053
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
728.88%Profit Margin
Profitable1.32MRevenue
9.59MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SCNI.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Show more...
CEO
ISIN
US09073Q3039
Listings
0 Comments
Share your thoughts
FAQ
What is Scinai Immunotherapeutics stock price today?▼
The current price of SCNI.BOATS is $0.58 USD — it has decreased by -4.18% in the past 24 hours. Watch Scinai Immunotherapeutics stock price performance more closely on the chart.
What is Scinai Immunotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Scinai Immunotherapeutics stocks are traded under the ticker SCNI.BOATS.
What is Scinai Immunotherapeutics revenue for the last year?▼
Scinai Immunotherapeutics revenue for the last year amounts to 1.32M USD.
What is Scinai Immunotherapeutics net income for the last year?▼
SCNI.BOATS net income for the last year is 9.59M USD.
When did Scinai Immunotherapeutics complete a stock split?▼
Scinai Immunotherapeutics has not had any recent stock splits.